Prepatellar BursitisMANAGEMENT

MUSCULOSKELETAL AND RHEUMATOLOGIC PRESENTATIONS · 12 SECTIONS

⚲

586 items

☷ Legend

01Approach to the Critical Patient/attcp35

Immediate priorities

›Septic bursitis vs non-septic distinction

›Key question driving all management decisions

›Fever >37.8°C strongly raises septic concern

›Rapid onset erythema and warmth with skin break

›Signs of systemic toxicity requiring urgent action

›Tachycardia and hypotension

›Rigors and high fever

›If systemic toxicity present, consider bacteremia or necrotizing soft tissue infection

›IV access and fluid resuscitation

›Blood cultures before antibiotics

Escalation triggers

›Criteria requiring urgent escalation

›Rapidly spreading cellulitis beyond bursa

›Proximal tracking of erythema

›Lymphangitic streaking

›Signs of necrotizing soft tissue infection

›Pain disproportionate to exam

›Skin necrosis or crepitus

›Surgical emergency

›Immunocompromised host with septic bursitis

›Diabetes mellitus

›Chronic corticosteroid use

›HIV or transplant recipient

›Failure to improve after 48 to 72 hours appropriate oral antibiotics

›Consider IV upgrade

›Repeat aspiration and culture

Key concepts

›Clinical pearls

›Preserved passive and active range of motion distinguishes bursitis from septic arthritis

›Critical differentiating finding

›Septic arthritis causes painful motion in all planes

›Bursal aspiration is both diagnostic and therapeutic

›Send cell count, culture, Gram stain, crystal analysis

›Sterile technique mandatory to prevent iatrogenic infection

›Approximately one-third of inflammatory bursitis cases are septic

›Staphylococcus aureus accounts for 73 to 80% of septic cases

›Streptococci account for approximately 19%

02History/hx55

Mechanism and onset

›Mechanism of injury

›Repetitive kneeling occupation

›Carpet layers, plumbers, roofers, mechanics, clergy

›Most common cause overall

›Direct acute trauma to anterior knee

›Fall onto kneecap

›Athletic contact injury

›Skin disruption overlying bursa

›Abrasions and lacerations

›Insect bites

Symptom characterization

›Pain and swelling pattern

›Anterior knee pain

›Worsened by kneeling or direct pressure

›Typically preserved weight-bearing ambulation

›Onset timing

›Insidious onset suggests chronic microtraumatic etiology

›Acute onset suggests traumatic, hemorrhagic, or septic etiology

›Swelling progression

›Gradual welling in chronic cases

›Rapid onset warmth and erythema raises septic concern

Alarm features

›Features suggesting septic bursitis

›Fever or chills

›Temperature >37.8°C

›Rigors

›Skin break overlying bursa

›Recent laceration, abrasion, or bite

›Purulent drainage

›Rapid progression of erythema and warmth

›Cellulitis pattern

›Skin temperature difference >2.2°C vs contralateral knee

›Systemic illness

›Malaise and myalgias

›Tachycardia

Risk factors

›Host and occupational risk

›Male sex

›Accounts for 80% of cases

›Age 40 to 60 years predominant

›Immunosuppression

›Diabetes mellitus

›Chronic corticosteroid use

›HIV and transplant recipients

›Alcoholism

›Inflammatory conditions

›Gout or pseudogout history

›Rheumatoid arthritis

›Prior bursitis episodes

›Recurrence is common

›MRSA colonization history increases risk

Important negatives

›Features suggesting intra-articular pathology rather than bursitis

›Locking or catching

›Suggests meniscal tear

›Giving way

›Suggests ligamentous instability

›Pain with all planes of ROM

›Suggests septic arthritis

03Physical Exam/exam52

Vitals and general

›Vital sign assessment

›Temperature

›Fever >37.8°C suggests septic bursitis

›Normal temperature does not exclude infection in immunocompromised

›Heart rate and blood pressure

›Tachycardia suggests systemic infection or bacteremia

›Hypotension rare but indicates severe sepsis

Local examination

›Anterior knee inspection

›Focal well-circumscribed swelling anterior to patella

›Not within the joint

›Directly over the kneecap

›Skin assessment

›Erythema and warmth suggest septic or inflammatory etiology

›Overlying skin breaks or draining sinuses

›Crepitus suggesting gas-forming organism

›Palpation findings

›Bursal characteristics

›Fluctuant tender swelling

›Well-circumscribed borders

›Skin temperature comparison

›Difference >2.2°C versus contralateral knee supports infection

›Bilateral comparison mandatory

Range of motion

›ROM assessment

›Passive and active knee ROM typically preserved

›Key distinguishing feature from septic arthritis

›Flexion may be limited by bursal tension at extremes

›If ROM is painful in all planes

›Consider intra-articular process

›Aspiration and imaging to exclude septic arthritis

Joint and regional exam

›Intra-articular assessment

›Patellar ballottement and tap

›Assess for intra-articular effusion

›Positive tap suggests septic arthritis rather than bursitis

›Joint line tenderness

›Medial and lateral compartments

›Meniscal pathology overlap assessment

›Regional lymphatic and vascular

›Inguinal lymphadenopathy

›Suggests septic process with regional spread

›Popliteal fossa

›Baker cyst exclusion

›Neurovascular status

›Distal pulses and sensation

PITFALLS

›Common diagnostic errors

›Confusing bursitis with septic arthritis

›Bursitis swelling is anterior and superficial to joint

›Septic arthritis fills the joint cavity

›Missing necrotizing soft tissue infection

›Pain disproportionate to appearance

›Gas on imaging is surgical emergency

›Assuming non-septic without aspiration in unclear cases

›Low threshold to aspirate when fever or skin break present

04Differential Diagnosis/ddx40

Life threats and urgent mimics

›Critical diagnoses not to miss

›Necrotizing fasciitis or myositis

›ICD-10 M72.6

›Pain disproportionate to appearance, gas on imaging, systemic toxicity

›Septic arthritis of the knee

›ICD-10 M00.9

›Painful restricted ROM in all planes, intra-articular effusion on imaging

›Bacteremia from septic bursitis

›ICD-10 A49.9 association

›Systemic toxicity, positive blood cultures

Common mimics

›Infectious and inflammatory

›Cellulitis without bursitis

›ICD-10 L03.115

›Diffuse non-fluctuant swelling, ultrasound differentiates

›Abscess

›ICD-10 L02.419

›Fluctuant collection, ultrasound shows rim enhancement

›Gout or pseudogout bursitis

›ICD-10 M10.062 (gout), M11.062 (pseudogout)

›Crystal analysis on aspirate is diagnostic

›Traumatic and structural

›Patellar fracture

›ICD-10 S82.00

›Point tenderness over patella, inability to extend knee, radiograph diagnostic

›Infrapatellar bursitis

›ICD-10 M70.50

›Swelling inferior to patella rather than directly anterior

›Morel-Lavallee lesion

›ICD-10 T14.8

›Post-traumatic closed degloving, MRI distinguishes from bursitis

Additional considerations

›Articular and soft tissue

›Meniscal pathology

›Mechanical symptoms, joint line tenderness, MRI diagnostic

›Ligamentous injury

›Mechanism of injury, laxity on stress testing

›Rheumatoid nodule or soft tissue tumor

›Firm non-fluctuant mass, imaging and biopsy if atypical

›Prepatellar bursitis

›ICD-10 M70.40

›SNOMED CT 57773001 prepatellar bursitis

05Laboratory Tests/lt33

Bursal fluid analysis

›Bursal aspiration — key diagnostic test for septic concern

›Cell count with differential

›WBC >3,000 cells per microlitre with >50% PMNs suggests infection

›Lower counts may still be septic, especially early or in immunocompromised

›Gram stain and culture

›Staphylococcus aureus in 73 to 80% of septic cases

›Streptococci in approximately 19%

›Guides targeted antibiotic therapy

›Crystal analysis

›Negatively birefringent under polarized light confirms gout

›Positively birefringent confirms pseudogout

›Glucose

›Fluid-to-serum glucose ratio <50% suggests infection

Serum laboratory tests

›Blood tests for suspected septic bursitis

›Complete blood count with differential

›Leukocytosis supports infection

›Elevated but non-specific

›C-reactive protein

›Elevated in septic bursitis

›Useful for trending treatment response

›Erythrocyte sedimentation rate

›Elevated in infection and inflammation

›Non-specific

›Serum glucose

›Diabetes screening in new diagnosis

›Required for fluid-to-serum glucose ratio

Microbiological

›Blood cultures

›Indication

›Systemic toxicity or fever with septic bursitis

›Immunocompromised host

›Timing

›Before antibiotics when feasible

›Two sets for adequate sensitivity

06Diagnostic Tests/dt61

Scoring Systems

›Septic bursitis clinical criteria

›No validated formal scoring system for prepatellar bursitis

›Clinical criteria guide septic vs non-septic distinction

›ACEP Level C recommendation for clinical gestalt approach

›Criteria supporting septic bursitis diagnosis

›Fever >37.8°C

›Overlying skin lesion or break

›Bursal WBC >3,000 cells per microlitre

›Positive Gram stain

›Severity stratification

›Mild non-septic: focal swelling, no systemic signs, preserved ROM

›Moderate septic non-toxic: warmth, erythema, mild fever, no systemic toxicity

›Severe septic toxic: high fever, extensive cellulitis, systemic illness

MRI

›MRI knee indications

›Not routine for typical prepatellar bursitis

›Diagnosis is usually clinical and ultrasound-guided

›Reserve for diagnostic uncertainty

›Indications for MRI

›Suspected osteomyelitis underlying bursitis

›Atypical presentation with firm mass

›Morel-Lavallee lesion evaluation

›Soft tissue tumor exclusion

›MRI findings in bursitis

›Fluid-signal collection anterior to patella

›Thickened bursal walls with inflammation

›Adjacent soft tissue edema in septic cases

›Contraindications

›Incompatible metallic implants

›Patient inability to cooperate

›CT knee indications

›Generally not indicated for uncomplicated bursitis

›Ultrasound and clinical exam usually sufficient

›Reserve for specific complications

›CT indications

›Suspected gas-forming organism or necrotizing infection

›Subcutaneous gas on plain radiograph requires CT characterization

›Bony involvement evaluation when osteomyelitis suspected

›CT findings

›Soft tissue emphysema indicates gas-forming organism

›Fluid collection anterior to patella

›Calcification in chronic bursitis

›Plain radiograph first

›Rule out patellar fracture

›Foreign body detection

›Usually normal in bursitis

Ultrasound

›Ultrasound for prepatellar bursitis

›First-line imaging modality

›Excellent for confirming bursal fluid collection

›Distinguishes bursitis from cellulitis and abscess

›Guides aspiration procedure

›Ultrasound findings

›Anechoic or hypoechoic fluid collection anterior to patella

›Septations or debris suggest septic or hemorrhagic etiology

›Hyperemia on Doppler in inflammatory bursitis

›POCUS guidance

›Real-time needle visualization during aspiration

›Reduces risk of dry tap

›ACEP Level B recommendation for ultrasound-guided aspiration

›Distinguishing from abscess

›Abscess typically has rim enhancement and surrounding cellulitis

›Bursitis is contained within bursal anatomy

07Disposition/dispo45

Admission indications

›Criteria requiring inpatient management

›Systemic toxicity from septic bursitis

›Fever >38.5°C with tachycardia

›Hypotension

›Rigors or altered mental status

›Inability to tolerate oral antibiotics

›Persistent vomiting

›Severe systemic illness

›Immunocompromised host with septic bursitis

›Diabetes with poor glycemic control

›HIV, transplant, or chronic steroid use

›Lower threshold for admission

›Failure of outpatient oral antibiotic therapy

›No improvement after 48 to 72 hours

›Worsening erythema or systemic signs

›Suspected necrotizing soft tissue infection

›Surgical emergency requiring immediate IV antibiotics and OR

›Extensive cellulitis surrounding bursitis

›Tracking or spreading infection

Discharge criteria

›Safe discharge criteria for septic bursitis

›Clinically well without systemic toxicity

›Afebrile or low-grade fever

›No tachycardia or hypotension

›Aspiration performed with appropriate cultures sent

›Gram stain reviewed when available

›Oral antibiotic therapy initiated

›Staphylococcal coverage confirmed

›Reliable follow-up confirmed within 24 to 48 hours

›Return precautions documented

›Non-septic bursitis discharge

›Conservative management appropriate

›NSAIDs prescribed

›Activity modification counseled

›Knee pad recommendation for occupational exposure

Follow-up planning

›Outpatient follow-up

›Septic bursitis

›Primary care or urgent care within 24 to 48 hours

›Culture results review and antibiotic adjustment

›Repeat aspiration in 24 to 48 hours if not improving

›Non-septic bursitis

›Primary care within 1 to 2 weeks

›Orthopedics or rheumatology referral for recurrent cases

›Occupational considerations

›Kneeling restriction during recovery

›Protective knee pad on return to work

08Treatment/t89

Non-septic bursitis management

›Conservative treatment

›NSAIDs first-line

›Ibuprofen 400 to 600 mg orally three times daily with food

›Duration 5 to 7 days typically

›Renal function and GI risk assessment before prescribing

›Naproxen 500 mg orally twice daily as alternative

›Duration 5 to 7 days

›Avoid in renal impairment

›Activity modification

›Avoidance of kneeling and repetitive pressure

›Padded kneeling surface if work demands continuation

›Ice and compression

›Ice application 15 to 20 minutes several times daily

›Compression wrap for comfort and swelling reduction

›Aspiration of non-septic bursitis

›Therapeutic aspiration acceptable for symptomatic relief

›Avoid unnecessary aspiration due to iatrogenic infection risk

Corticosteroid injection

›Corticosteroid use in non-septic bursitis

›Consideration criteria

›Confirmed non-septic bursitis

›Significant occupational or athletic functional demand

›Failure of conservative measures

›Corticosteroid options

›Methylprednisolone acetate 20 to 40 mg intrabursal injection

›Combined with lidocaine 1% for comfort

›Single injection preferred

›Triamcinolone acetonide 10 to 20 mg intrabursal injection

›Alternative preparation

›Evidence and limitations

›High-quality evidence of benefit is limited

›Contraindicated when infection is suspected

›Risk of worsening septic bursitis if misdiagnosed

Septic bursitis antibiotics — outpatient

›Oral regimens for non-toxic septic bursitis

›First-line MSSA coverage

›Cephalexin 500 mg orally four times daily

›Minimum 14 days duration

›Treatment less than 14 days associated with higher failure rates

›Dicloxacillin 500 mg orally four times daily

›Take on empty stomach for optimal absorption

›Minimum 14 days duration

›MRSA risk present

›Trimethoprim-sulfamethoxazole DS one tablet orally twice daily

›If local MRSA prevalence warrants

›Assess sulfa allergy history

›Doxycycline 100 mg orally twice daily

›MRSA alternative when sulfa contraindicated

›Minimum 14 days duration

Septic bursitis antibiotics — inpatient IV

›Intravenous regimens for severe or toxic septic bursitis

›MSSA presumptive coverage

›Nafcillin 1 to 2 g IV every 4 to 6 hours

›Preferred for confirmed MSSA

›Hepatic metabolism

›Cefazolin 1 to 2 g IV every 8 hours

›Equivalent antistaphylococcal activity

›Renal dosing adjustment required

›MRSA coverage when risk factors present

›Vancomycin IV 15 to 20 mg per kg every 8 to 12 hours

›AUC-guided dosing per local protocol

›Target AUC 400 to 600 mg x h per litre

›Renal function monitoring

›Daptomycin 4 to 6 mg per kg IV daily as alternative

›Not for pulmonary infection concurrent use

›CK monitoring with prolonged use

›Duration

›IV until clinically stable and afebrile

›Transition to oral to complete minimum 14 days total

Procedural treatment

›Bursal aspiration technique

›Sterile technique mandatory

›Skin preparation with antiseptic

›Sterile draping and gloves

›Needle selection

›18 to 20 gauge needle for aspiration

›Ultrasound guidance preferred

›Sample processing

›Cell count and differential

›Gram stain and aerobic culture

›Crystal analysis under polarized microscopy

›Glucose if septic bursitis suspected

›Repeat aspiration for septic bursitis

›Re-aspirate at 24 to 48 hours to assess response

›Serial aspirations may be needed

›Surgical referral indications

›Failed repeated aspiration and antibiotics

›Persistent septic bursitis

›Chronic thickened bursal wall

›Necrotizing infection

›Emergency surgical debridement

›Chronic recurrent bursitis with functional impairment

›Bursectomy consideration

09Special Populations/sp59

Pregnancy

›Pregnancy considerations

›Diagnosis and imaging

›Clinical diagnosis first-line

›Ultrasound preferred imaging modality

›Plain radiograph with fetal shielding acceptable if fracture excluded needed

›Antibiotic safety

›Cephalexin generally safe in pregnancy

›Category B

›Preferred first-line for septic bursitis

›Avoid trimethoprim-sulfamethoxazole in first trimester and near term

›Neural tube defect risk in first trimester

›Kernicterus risk near term

›Avoid tetracyclines

›Fetal tooth and bone effects

›NSAID considerations

›Avoid after 20 weeks gestation

›Premature ductus arteriosus closure risk

›Acetaminophen preferred for pain in second and third trimester

›Consultation

›Obstetrics involvement for systemic infection in pregnancy

Geriatric

›Older adult considerations

›Atypical presentation

›Fever may be absent even with septic bursitis

›Baseline functional decline as severity marker

›Delirium as presenting symptom

›Pharmacologic adjustments

›NSAID use with caution

›Renal impairment risk

›GI bleeding risk higher

›Fluid retention and heart failure risk

›Vancomycin renal dosing

›Reduced creatinine clearance requires dose interval adjustment

›Close monitoring essential

›Comorbidity burden

›Diabetes increases septic bursitis risk and severity

›Immunosuppression common in this age group

›Disposition bias toward admission

›Limited home support

›Frailty and fall risk with swollen knee

›Higher failure rate with outpatient management

Pediatrics

›Pediatric considerations

›Prepatellar bursitis less common in children

›Consider when traumatic mechanism present

›Sports participation and direct contact injury

›Antibiotic dosing weight-based

›Cephalexin 25 to 50 mg per kg per day orally divided every 6 hours

›Maximum adult dose applies

›Clindamycin 10 to 13 mg per kg per day orally divided every 8 hours if MRSA risk

›Maximum 300 mg per dose

›NSAID dosing

›Ibuprofen 5 to 10 mg per kg orally every 6 to 8 hours

›Maximum 40 mg per kg per day

›With food to reduce GI irritation

›Septic arthritis exclusion priority

›Children with knee pain and fever require urgent evaluation

›Kocher criteria for septic arthritis consideration

›Child protection consideration

›Unusual mechanism or inconsistent history requires assessment

›Non-accidental trauma screening when indicated

10Background/b56

Epidemiology

›Incidence and demographics

›Minimum annual incidence approximately 10 per 100,000 population

›Likely underestimated due to mild cases managed outside emergency care

›Sex distribution

›80% male predominance

›Peak age 40 to 60 years

›Septic vs non-septic proportion

›Approximately one-third of inflammatory cases are septic

›Two-thirds are non-septic

›Occupational association

›Carpet layers, plumbers, roofers, and gardeners at highest risk

›Clergy and wrestlers also high-risk occupations

›Microbiology of septic cases

›Staphylococcus aureus 73 to 80%

›Streptococci 19%

›Overall treatment failure rate approximately 5.9%

Pathophysiology

›Mechanism of injury

›Bursal anatomy

›Prepatellar bursa sits between skin and anterior patella

›Normally contains minimal synovial fluid

›Friction-reducing function during kneeling

›Non-septic inflammation

›Repetitive microtrauma causes bursal wall thickening

›Increased vascular permeability leads to fluid accumulation

›Chemical irritation from trauma products

›Septic bursitis mechanism

›Direct inoculation via skin break most common route

›Hematogenous seeding less common

›Staphylococcus aureus predominates due to skin flora origin

›Crystal-induced bursitis

›Urate crystal deposition in gout

›Calcium pyrophosphate in pseudogout

›Intense inflammatory response triggered by crystal phagocytosis

›Hemorrhagic bursitis

›Direct vascular disruption from trauma

›Anticoagulant use increases risk

Therapeutic Considerations

›Key therapeutic principles

›Septic vs non-septic distinction drives all treatment decisions

›Corticosteroids contraindicated in septic bursitis

›Antibiotics not needed in non-septic bursitis

›Aspiration strategy

›Diagnostic aspiration warranted when septic concern exists

›Avoid routine aspiration of chronic non-septic bursitis

›Iatrogenic infection risk from unnecessary aspiration

›Antibiotic duration principles

›Minimum 14 days established by clinical evidence

›Shorter courses associated with higher recurrence

›Culture guidance allows de-escalation

›Recurrence prevention

›Occupational kneeling restriction key

›Protective padding on return to kneeling work

›Surgical bursectomy for refractory chronic cases

›Evidence base

›No large randomized controlled trials specific to prepatellar bursitis

›Management extrapolated from observational studies and expert consensus

›ACEP Level C recommendation for most management decisions

11Patient Discharge Instructions/pdi39

copy discharge instructions

›Prepatellar bursitis home care

›Rest the knee and avoid kneeling

›No kneeling on hard surfaces during recovery

›Use a knee pad if you must kneel for work

›Ice the front of the knee

›15 to 20 minutes at a time

›Several times daily for the first 48 to 72 hours

›Keep the knee elevated when resting

›Reduces swelling

›Take medications as prescribed

›Anti-inflammatory medication with food

›If antibiotics prescribed, complete the full course even if feeling better

›Antibiotic course instructions

›Complete all antibiotics as directed

›Stopping early increases risk of treatment failure and recurrence

›Minimum 14 days is typically required

›Take with a full glass of water

›Some antibiotics require empty stomach

›Ask your pharmacist for specific instructions

›Warning signs to return to ER immediately

›Spreading redness beyond the swollen area

›Tracking red lines up the leg

›Fever above 38.5°C

›Especially if not improving on antibiotics

›Worsening pain or rapidly enlarging swelling

›Pus or discharge from the skin

›Feeling unwell, chills, or shaking

›Inability to bear weight on the leg

›Follow-up instructions

›Return to your doctor within 24 to 48 hours if antibiotics prescribed

›Culture results will be reviewed

›Treatment adjustment may be needed

›If no antibiotics prescribed, follow up in 1 to 2 weeks

›Sooner if symptoms worsen

›Chronic or recurrent cases may need orthopedic referral

›Prevention tips

›Always use knee pads when kneeling on hard surfaces

›Alternate kneeling positions during prolonged work

›Treat skin cuts and scrapes over the knee promptly to prevent infection

12References/r22

Guidelines and key sources

›Clinical references

›Blackwell JR, Hay BA, Bolt AM, Hay SM. Olecranon bursitis: a systematic overview. Shoulder Elbow. 2014

›Principles extrapolated to prepatellar bursitis management

›Reilly D, Kamineni S. Olecranon bursitis. J Shoulder Elbow Surg. 2016

›Bursitis management framework applicable to prepatellar site

›Garcia-Porrua C, Gonzalez-Gay MA, et al. Comparison of infectious and non-infectious bursitis. Rheumatology. 1999

›Epidemiology of septic vs non-septic bursitis

›Laupland KB, Davies HD. Olecranon septic bursitis managed in an ambulatory setting. Ann Rheum Dis. 2001

›Antibiotic duration and recurrence data

Evidence levels

›ACEP guideline evidence levels applied

›Level A: RCT or meta-analysis with consistent results

›No Level A evidence specific to prepatellar bursitis

›Level B: Non-randomized trials, observational studies

›Ultrasound-guided aspiration recommendation

›Level C: Expert consensus or extrapolated evidence

›Antibiotic selection and duration

›Septic vs non-septic management decisions

Coding standards

›ICD-10 and coding references

›ICD-10 M70.40 prepatellar bursitis unspecified knee

›ICD-10 M70.41 prepatellar bursitis right knee

›ICD-10 M70.42 prepatellar bursitis left knee

›SNOMED CT 57773001 prepatellar bursitis disorder

Learn More: Prepatellar Bursitis→

Comprehensive Clinical Review

Structured, evidence-informed, long-form analysis for deeper understanding.

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed June 16, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.